| Names | |
|---|---|
| Preferred IUPAC name | (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one |
| Other names | Vitamin C L-ascorbic acid 3-Oxo-L-gulofuranolactone AA |
| Pronunciation | /əˈskɔːrbɪk ˈæsɪd/ |
| Identifiers | |
| CAS Number | 50-81-7 |
| Beilstein Reference | 12006 |
| ChEBI | CHEBI:29073 |
| ChEMBL | CHEMBL50 |
| ChemSpider | 5363 |
| DrugBank | DB00126 |
| ECHA InfoCard | 100.011.738 |
| EC Number | 3.1.1.15 |
| Gmelin Reference | 9197 |
| KEGG | C00072 |
| MeSH | D001362 |
| PubChem CID | 54670067 |
| RTECS number | CI7650000 |
| UNII | 'PQ6CK8PD0R' |
| UN number | UN3076 |
| Properties | |
| Chemical formula | C6H8O6 |
| Molar mass | 176.12 g/mol |
| Appearance | A white or almost white, crystalline powder or colourless crystals. |
| Odor | Odorless |
| Density | 1.65 g/cm³ |
| Solubility in water | 330 g/L (20 °C) |
| log P | -1.85 |
| Vapor pressure | Vapor pressure: <0.1 hPa (20 °C) |
| Acidity (pKa) | 4.10 |
| Basicity (pKb) | 8.5 |
| Magnetic susceptibility (χ) | Diamagnetic |
| Refractive index (nD) | 1.62 |
| Viscosity | Low viscosity |
| Dipole moment | Dipole moment of Ascorbic Acid: "3.97 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 176.0 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -463.0 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1986 kJ/mol |
| Pharmacology | |
| ATC code | A11GA01 |
| Hazards | |
| Main hazards | May cause mechanical irritation to eyes, skin, and respiratory tract. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | P264, P270, P301+P312, P330, P501 |
| NFPA 704 (fire diamond) | 1-0-0-W |
| Flash point | 185°C |
| Autoignition temperature | 660 °C (1220 °F; 933 K) |
| Lethal dose or concentration | LD50 (oral, rat): 11,900 mg/kg |
| LD50 (median dose) | LD50 (median dose): 11,900 mg/kg (oral, rat) |
| NIOSH | WN6500000 |
| PEL (Permissible) | PEL: Not established |
| REL (Recommended) | 100 mg |
| IDLH (Immediate danger) | No IDLH established |
| Related compounds | |
| Related compounds | Dehydroascorbic acid Erythorbic acid Isoascorbic acid Calcium ascorbate Sodium ascorbate Magnesium ascorbate Ascorbyl palmitate |
| Property | Manufacturer Commentary |
|---|---|
| Product Name | Ascorbic Acid |
| IUPAC Name | (5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one |
| Chemical Formula | C6H8O6 |
| Synonyms & Trade Names | Vitamin C, L-ascorbic acid, Antiscorbutic vitamin |
| CAS Number | 50-81-7 |
| HS Code & Customs Classification | 2936.27 (Based on global harmonized tariff codes for vitamins and their derivatives; regional subclassification may apply for specific formulations, salt forms, or blends) |
Ascorbic Acid production on an industrial scale relies on a dual-pathway synthesis, typically the Reichstein process or two-step fermentation from glucose. Raw materials for both routes require stringent incoming control; glucose purity and microbial profile directly affect downstream impurity patterns. Simple chemical tests are not sufficient; most manufacturers operate validated HPLC and microbial assays at reception and for continuous monitoring.
Industrial batches display slight differences in crystalline morphology due to variations in temperature ramp rates, seed crystal quality, and solvent recovery cycles. Physical characteristics, such as particle size and agglomeration, are monitored using laser diffraction, which report grade-sensitive outputs. Cosmetic ingredient artisans, food and beverage processors, and pharma formulation teams expect particle size distributions tailored to their mixing, dissolution, and filtration systems. For injection-grade Vitamin C, trace metals originating from process water or equipment contacts—iron, copper, nickel—become specification-critical. Here, high-purity water systems, acid-resistant construction materials, and in-process chelation are essential to manage risk.
Evaluating HS Code and customs classification for ascorbic acid depends on product presentation (pure substance, mixture, or finished dosage form). Inconsistent documentation or blend additions can trigger classification disputes at borders, resulting in delays or rejections; regulatory and shipping teams must provide origin data, granulation method records, and blend certificates as needed. Internal tracking links each consignment to a detailed batch dossier, combining analytical results, process parameters, and regulatory evaluation to ensure traceability and compliance with export and import regulations.
Key control points across production include glucose conversion completeness, fermentation endpoint determination, and the management of side-product purge streams. Key sources of impurity include incomplete conversion, fermentation byproducts, and degradation during crystallization or drying. Purification routes may involve activated carbon, selective recrystallization, and membrane filtration. Specifications for physical and chemical properties are always defined according to application: food, feed, or pharma; within each segment, customer-preferred details guide internal batch release protocols.
In industrial batches, ascorbic acid occurs as a white to pale yellow crystalline powder or granule. Bulk material in its freshly manufactured state displays no noticeable odor. The appearance may show minor variations depending on crystallization procedures and purity targets specified for food, pharma, or feed grades. Melting point and particle morphology can shift with grade; melting onset is typically observed above 190°C, with decomposition evident before reaching a true boiling phase due to thermal instability.
Material remains sensitive to oxidizing conditions; exposure to air, trace metals, alkali, or elevated humidity accelerates oxidation, turning powder yellow and decreasing potency. Pure product keeps best under inert atmospheres and sealed containment. Rates of degradation depend on storage, trace metal content, and pH of solution. Builders pay special attention to inner packaging choice when targeting sensitive formulations in food and pharma.
Ascorbic acid shows high solubility in water, with rapid dissolution favored by gentle stirring and moderate temperatures. Hydration exotherm is minor and inconsequential at standard industrial solution preparations. Solubility and solution stability drop off with rising pH; alkaline media prompt rapid hydrolysis and oxidation, especially above neutral pH or in the presence of transition metals. Freshly prepared solutions are demanded for analytical work and processing where retention of ascorbate function is critical.
Quality standards show pronounced differences based on sector: food, pharmaceutical, technical, or feed. Particle size, ascorbate assay, purity, and impurity profile shift as per intended end-use and relevant codex, pharmacopeia, or industrial requirements. Exact values for assay, heavy metals, or microbial load depend on release programs tailored per customer or regulatory need.
Process-specific impurities stem from fermentation residues, oxidation byproducts, or processing aids left over from raw material streams. Control points include close monitoring of color, pH, and chromatography profiles. Typical critical impurities: dehydroascorbic acid, residual fermentation nutrients, and trace transition metals. Pharmaceutical- and food-grade requirements enforce tighter impurity and residual solvent specifications than industrial grades.
Release testing applies titrimetric, HPLC, or UV-Vis methods, with reference to either internal protocols or official compendial standards such as USP, EP, or GB, depending on customer and regulatory region. Test frequency and acceptance windows are determined by batch scale and risk assessment outcomes. Routine batches see periodic retesting to monitor shelf degradation, especially in high-sensitivity applications.
Ascorbic acid production relies heavily on glucose or sorbitol from starch hydrolysates, preferably sourced from non-GMO routes if market requirements dictate. Fermentation strains are selected for high yield and robustness under industrial conditions, with process adjustments made in response to variations in feedstock quality.
Commercial synthesis employs a multi-step process. Most modern systems utilize microbial fermentation to convert sugars into key intermediates, which are then subjected to chemical transformation via catalytic hydrogenation and controlled oxidation steps. Isolation of ascorbic acid depends on precise control of pH, temperature, and redox environment. Alternative chemical routes persist in some markets but are less favored due to cost and impurity control challenges.
Critical checkpoints include stagewise pH adjustment, impurity removal by crystallization and/or adsorption, and filtration to meet particle size and clarity requirements. Oxidation control at the intermediate and finishing stages receives priority, with closed systems and inert atmospheres often used to suppress ascorbate degradation. Batch consistency depends on tight monitoring of input sugar purity and fermentation byproducts.
Final release criteria span visual inspection, assay for ascorbate content, impurities by chromatography, and metal analysis, with batch record review by in-house quality assurance. Testing protocols consider degradation during storage, so some grades undergo accelerated stability testing. Release standards may differ in global supply chains, subject to customer audit and compliance agreements.
Ascorbic acid undergoes facile redox reactions, readily forming dehydroascorbic acid in the presence of oxygen or oxidants. At elevated pH or in metal-rich environments, breakdown proceeds further to diketogulonic acid and fragment species. Under mild conditions, ascorbate serves as a reducing agent in industrial syntheses and as a stabilizer against oxidative processes in functional mixtures.
Key reactions utilize aqueous or mixed polar solvent systems, with control of oxygen exposure paramount. No precious metal catalysts are required under normal process chemistry, though trace metals post-fermentation necessitate rigorous removal. All downstream processing is configured to minimize heat load and exposure to light.
Production streams often divert purified ascorbate to formulation with sodium or calcium salts for specialty markets. Esterification yields derivatives such as ascorbyl palmitate, favored in fat-soluble antioxidant applications. By-product management and potential valorization are key for modern sustainability targets.
Bulk ascorbic acid requires storage in cool, dry, and dark spaces, protected from direct light and air ingress. Primary containment relies on lined fiber drums or composite bags with high-barrier liners. Temperature excursions or breached seals speed discoloration and purity loss. Humidity spike events show rapid caking and potency dropoff.
Contact materials must not leach metals or promote static charge. Polyethylene, polypropylene, or multilayer composite containers meet protection needs without contributing extractables. Use of metal is limited to externally lined sources due to risk of ascorbate-metal interaction.
Shelf life depends on both grade and storage controls, with food and pharma grades often guaranteed for 24-36 months if containment remains uncompromised. Discoloration to yellow, formation of clumps, or any sour off-odor signals breakdown and potentiates recall investigation. Regular retesting of retained samples provides the data backbone for shelf-life assurance.
Ascorbic acid commonly falls outside acute toxic or corrosive categorizations under GHS; direct handling presents low risk at industrial exposure levels. Fine dust or bulk powder handling can generate airborne nuisance particulates, making appropriate dust extraction standard practice on our lines.
Technical and production staff adhere to basic PPE protocols: gloves, goggles, and dust masks where powder generation risks arise. Bulk dust event mitigation includes local ventilation and monitored housekeeping. Ocular or dermal contact poses only mild irritation risk, but should not be disregarded.
Toxicological history indicates very low hazard to humans at dietary and incidental industrial contact levels, with no evidence of carcinogenic or mutagenic effects in standard animal testing. Ingestion of high concentrations causes gastrointestinal upset in sensitive individuals.
Standard workplace exposure guidance focuses on particulates rather than active toxicity thresholds. House production lines feature closed transfer for bulk movement. Emergency provisions call for eyewash and prompt decontamination of skin if accidental exposure occurs during blending or packaging.
Current operational lines focus on varied grades of ascorbic acid, including food, pharma, and feed applications. Annual output depends on fermentation performance, raw glucose quality, and filtration yield. Bottlenecks frequently result from upstream fermentation vessel reliability and downstream purification capacity, especially for high-purity and injectable grades. Availability hinges on seasonal plant utilization, major shutdowns for equipment overhaul, and regional feedstock cost swings, particularly for corn-based input. Unplanned outages and force majeure declarations at key Chinese and European plants in recent years have led to severe global tightness, highlighting the need for buffer inventory and robust supplier relations.
Lead time is heavily dependent on grade and lot size. Standard food and feed grades usually ship within two to three weeks from confirmed order when packaging and documentation align with standard stock keeping. Pharmaceutical and ultrapure grades typically require additional release testing, often extending lead times to four to eight weeks. Minimum order quantity reflects both packaging format and utilization of dedicated line campaigns. Bulk shipments in 25 kg fiber drums or intermediate bags allow flexible MOQs, with certain direct API buyers requiring full-container or campaign batch volumes.
Packaging selection relates to moisture sensitivity, potential for oxidation, and contamination risk. Food-grade is commonly filled in lined fiber drums or kraft bags with double PE liners. The pharma sector demands HDPE drums with triple-layer barrier and full batch traceability. For feed and premix, composite bags provide a compromise between shelf-life management and logistics cost. Deviations in packaging structure often stem from buyer validation protocols or region-specific shipment regulations.
Shipping switches between FOB and CIF terms depending on region and forwarder capacity constraints. Tightened security and import documentation rules in the US, EU, and Japan have resulted in lengthier customs clearance for API grades. Payment terms for established customers trend toward 30–60 day net, whereas new or high-volume buyers may face irrevocable LC or cash in advance until quality and delivery reliability are verified through several cycles.
The cost of technical-grade glucose or dextrose, which serves as the feedstock for fermentation, makes up a substantial portion of ascorbic acid production cost. Fermentation yield loss, purification chemical consumption (notably activated charcoal, ion exchange resins), utilities, and waste treatment—all factor into batch profitability calculations. Upward moves in corn futures typically lead to a delayed but significant increase in production cost, especially in China, the world’s largest supply base.
Feedstock pricing, driven by agricultural commodity cycles and weather disruption, often triggers the most pronounced cost swings. Recovery rates in the fermentation step, maintenance turnaround timing, and yield efficiency improvements all contribute. Environmental regulation shifts—such as mandatory wastewater treatment upgrades or emission caps—add compliance costs, occasionally shifting spot prices upward for months at a time. Regulatory inspections or quality audits at primary plants in China and India sometimes precipitate temporary export licenses suspensions, squeezing spot supplies.
Price bands reflect both grade and use. Food-grade powder, with moderate purity standards, generally trades at the lowest tier, while API and injectable grades command a premium due to lower trace metal and bioburden specifications, more frequent batch validation, and full GMP and DMF support. Further division results from packaging complexity and region-specific certification requirements (e.g., USP/JP/EU/IN/GB monographs). Compliance with Halal, Kosher, and allergen-free declarations may affect batch scheduling and traceability, causing tailored price uplift.
China provides the majority of world ascorbic acid supply due to scale advantages and vertical integration of corn processing. Demand spikes in the US and Europe crease the global price curve, especially when domestic plants operate at sub-optimal rates or face regulatory scrutiny. APAC and Latin America see ongoing growth in food and animal feed fortification, driving continual spot market absorption.
The US and EU focus on high-specification pharma and food markets with stricter contaminant and traceability demands, sourcing both local and imported feedstock. Japan’s preference for domestic and Japan-certified origins keeps imported Chinese product at arm’s length unless full audit access is granted. India’s recent investments aim at backward integration but still import considerable volume for local conversion. China remains the cost-setter and swing producer, with output dictated by internal policy and utility costs.
Given current capacity announcements and new environmental compliance investments in China, base price is likely to trend slightly higher through 2026, with volatility around crop failures, policy shifts, or major regulatory events. Data referenced includes public customs and shipment statistics, published quarterly earnings updates of global vitamin suppliers, and market trend reports from established chemical tracking agencies. Forecasting methodology integrates raw material indexation, announced capacity projects, and seasonality impacts on fermentation yields.
Increased scrutiny on water and power consumption in primary Chinese production regions has already caused annual plant production cycles to shift, impacting global contract durations. Export license controls and capacity rationalizations have contributed to unpredictable availability for bulk and packaged shipments.
Stricter environmental and food safety authority oversight across China, the EU, and US have necessitated new process documentation, formal third-party audit programs, and trace metals reporting even for non-pharma applications. Buyers now demand electronic batch records and transport validation reports covering each shipment transit leg.
Investment in process analytics, real-time batch tracking, and advanced waste water treatment have reduced non-conforming batch rates and improved yield reliability. Collaboration with logistics partners to secure temperature and humidity traceable transit is now standard for high-purity output. Long-term offtake contracts and dual-source development with downstream major buyers have become more common as insurance against force majeure risks and allocation strategy events.
Ascorbic acid, produced in dedicated manufacturing lines, finds application across multiple sectors. In our technical teams’ experience, three industries dominate demand: food and beverage, pharmaceutical, and industrial chemical processing. Each application places distinct demands on the grade and purity profile.
From an industrial supply viewpoint, the choice of grade directly shapes product performance:
| Grade | Common Applications | Grade-Driven Parameter Focus |
|---|---|---|
| USP/Pharma | Tablets, injectables, medical nutrition | Impurity profile, analytical purity, trace metal content, bacterial load |
| FCC/Food | Food fortification, beverages, bakery, snacks | Sensory impact, dissolution, mesh size, absence of off-flavors |
| Technical | Chemical synthesis, cosmetic antioxidant, process stabilizer | Functional ascorbate content, cost structure, particle flow |
During batch release, we match parameters to use-case:
Production specialists start by clarifying process end-use: dietary, medical use, or chemical processing. Application scope drives nearly every downstream specification, from particle size to trace impurity threshold.
Quality control teams review compliance needs. For pharmaceuticals, regional pharmacopeia (USP, JP, EP) requirements set minimum test items. Food applications reference FCC or regional food safety standards. Non-food, non-pharma applications depend on customer-led specification sheets or relevant local statutes.
Grading reflects permitted impurity limits and the extent of purification. For example, pharmaceutical buyers typically demand the narrowest impurity window, requiring more stringent manufacturing supervision and downstream analytics. By contrast, food applications tolerate wider windows but scrutinize raw material origin and batch traceability.
Site managers and purchasing teams weigh monthly tonnage, shipping modes, and warehouse constraints. Large-volume contracts often enable process optimization to dial in cost per kilogram, targeting technical or food grades where budget is a key constraint.
Once a working grade is chosen, most manufacturers prefer to run a pilot or validation batch. Samples allow downstream QA and R&D teams to confirm fit compatibility—dissolution, solubility, blending, and possible interaction with formulation excipients. Feedback then refines the supply agreement, locking in grade, lot sizes, and documentation requirements.
All production facilities operate under ISO 9001-certified quality management systems. This framework grounds day-to-day control in documented procedures, traceable recordkeeping, and staff technical training. Consistency across batches generates confidence at each production stage. Audits by national and international bodies challenge the robustness of control points, from raw material vetting through final product release.
For pharmaceutical and food grades, regulatory compliance such as GMP (Good Manufacturing Practice) or FSSC 22000 is mandated by customers requiring full traceability and handling segregation. Implementation depth aligns with product grade and application sector. Internal QA/QC staff coordinate real-time monitoring and regular system reviews to address evolving regulatory expectations.
Ascorbic acid for food, beverage, pharmaceutical, and supplement markets often demands additional certifications. Where necessary, production lines undergo audits for Kosher, Halal, non-GMO, or allergen-free status. Certification validity and production line segregation protocols are grade- and application-driven. Where international pharmacopoeia standards apply (USP, EP, JP, etc.), testing is grade-specific and verified batchwise.
Each consignment ships with a Certificate of Analysis that reflects batch-specific analytical data – parameter scope is tied to both grade and downstream requirements. Upon request, further documents cover traceability, manufacturing route information, and third-party inspection reports. Consistency in documentation eases downstream regulatory checks and reduces source risk for direct processors and formulators.
Production scheduling prioritizes long-term partners requiring uninterrupted supply for continuous manufacturing and formulation. Multi-line capability and raw material sourcing resilience blunt seasonal or logistics disruptions. Buffer stock solutions and reserved production windows are subject to negotiation, with flexibility in shipment volume and delivery intervals. Supply resilience is negotiated based on forecast stability and historic order patterns.
Facility scale and manufacturing route selection depend on the technical grade and intended sector. Pharmaceutical and food-grade lines typically utilize continuous purification flow control, with in-process analytics to monitor critical attributes. Output is guided by historical demand, fixed framework agreements, and planned maintenance. For less specification-sensitive applications, batch production routes allow rapid ramp-up and custom packaging flexibility.
Sample requests are evaluated based on technical use case, grade, and target geography. Key application details and volume estimates inform the choice of batch and packaging. Customers submitting technical queries or formulation requests gain priority sampling to support evaluation and scale-up feasibility. Documentation supplied with samples aligns with potential downstream compliance and registration needs. Follow-up technical support is available for methods and stability queries during the customer’s evaluation window.
Supply agreements can be structured for monthly, quarterly, or annual offtake, or tailored to project-driven schedules. Volume and packaging format adjustment depends on the customer’s processing environment and stock turnover. VMI (Vendor Managed Inventory), logistics integration, or just-in-time supply are all available for high-volume partners with clear production forecasts. Collaborative planning reduces inventory risk on both sides and enables joint management of unforeseen market or regulatory requirements.
Industrial R&D concentrates on improving fermentation yield, reducing by-product load, and optimizing upstream carbon source utilization. Route selection—whether using the Reichstein process or the two-step fermentation method—directly impacts energy consumption and impurity spectrum. Continuous efforts target minimizing residual byproducts such as 2-keto-L-gulonic acid and regulated elemental contaminants introduced by raw material variability. Downstream, the particle size and flow behavior receive special attention, especially for direct compression and instant-mix beverage industries. Stabilization during storage and transit, especially for food and pharmaceutical grades, remains an active research interest.
New technical applications emerge in functional food fortification, animal feed premixes, auto-oxidation prevention in polymers, and clean-label crop protection. These demand batch-to-batch stability and process-driven customization in terms of granule profile, anti-caking performance, and hygroscopicity control. In pharmaceutical intermediates, producers must include robust controls for heavy metals and process solvents. Electrochemical and cosmetic customers seek solutions tailored to their oxidative stability and dispersibility requirements.
Process stability under variable fermentation feeds increases the risk of impurity carryover. Consistent ascorbic acid crystallization under humidity control is paramount, requiring real-time analytical checks. Innovations in green extraction solvents and closed-loop mother liquor recycling have started to lower chemical waste. The main challenge lies with maintaining downstream purity and color indices at scale, as minor changes in fermentation parameters result in batch-specific attributes. Progress has been made in inline process analytical technology, allowing feedback loops that reduce off-spec rejection rates.
Forecasts indicate growing demand for premium and specialty grades, particularly in regions phasing in fortification legislation and clean-label initiatives. Volume swings arise from regulatory developments in the nutritional and pharmaceutical sectors, often driving differential growth by region and application. Demand for water-soluble powders, direct compressible grades, and custom-formulated blends shapes investment in plant flexibility.
Production lines move toward automation and modular batch size capabilities, allowing rapid switchover between food, feed, and pharma grades. Active work aims to decentralize raw material supply, minimizing upstream risk in glucose sourcing. Trend analysis points toward further adoption of integrated quality management systems, as regulatory pressure on process transparency and traceability continues to increase. Reagent minimization, solvent recovery, and digitally monitored granulation have shown success in improving both yield and output consistency.
Life cycle assessments of traditional and two-step fermentation routes identify primary environmental loads at solvent use, utility consumption, and mother liquor disposal. Process choices now emphasize water reuse, raw material footprint reduction, and closed-loop utilities. Specific process upgrades replace mineral acid purification with ion-exchange or membrane alternatives in some specialty applications. Ongoing projects work to eliminate single-use filter aids and switch to renewable energy sources where grid infrastructure allows. Documentation of product carbon footprint and responsible sourcing forms part of customer-facing technical dossiers.
Our technicians offer guidance on grade selection based on end-use: food, pharma, feed, or technical markets. Staff help interpret specifications for particle size, solubility, and impurity profile according to downstream process requirements. Support evaluates the impact of formulation pH, ionic strength, and exposure to high-shear mixing. Consultation addresses pre-blending order, optimal dissolving procedures, and storage compatibility with co-formulants.
Technical teams provide application trials and protocol transfer for customers shifting grade or switching suppliers. On-site process audits can identify root causes of caking, loss of flowability, or color instability during product storage and downstream blending. Feed and nutrition customers access nutrient interaction data, helping them comply with ration balancing. Our support adapts specification release to suit unique country, regulatory, or assay sensitivity needs, with documentation in line with audit and full-traceability standards.
Complaint handling relies on batch-specific investigation records and retrievable archive retention. Analysis protocols support the rapid identification of off-grade material, supported by customer-accessible certificates of analysis and real-time batch history. Repeat supply contracts include periodic requalification and on-site technical visits if critical process changes arise. Shelf-life management guidance is provided according to particular storage climate, packaging configuration, and handling frequency stipulated by the customer.
Decades of experience guide our production of ascorbic acid across every batch. In-house facilities manage fermentation, purification, and crystallization under rigorous controls. We operate from raw materials through finished crystalline products without outsourcing any step. This direct control safeguards both physical and chemical purity, allowing us to meet large-scale B2B demand with traceable, repeatable output. Continuous investment in process engineering reduces contamination risk while supporting high throughputs.
Major food processors, beverage companies, pharmaceuticals, animal nutrition plants, and cosmetics manufacturers rely on our material for diverse applications. Ascorbic acid works as an antioxidant in beverages, preserves color and freshness in processed foods, and delivers measured performance in feed and vitamin blends. Its reducing properties also fit technical uses in polymerization and photographic chemistry. Ongoing technical dialogue with customers shapes particle size, density, flow, and solubility characteristics to requirements unique to each application.
Production adheres strictly to international standards for ascorbic acid. Each lot undergoes validated testing in our laboratory for potency, heavy metals, microbial profile, and physical parameters. Automated in-line analytical platforms reduce human error and allow for statistical process control, so batch variation remains minimal even at high volumes. Certificates of analysis back shipments, based on our own controlled test records. Recalls and compliance audits are rare, as we audit both incoming materials and finished product integrity by batch, without third-party intermediaries.
Ascorbic acid leaves the site packed under controlled conditions to prevent moisture ingress and avoid caking. Available packing options include fiber drums, heat-sealed PE bags, and multi-layer composite sacks suited to bulk material handling equipment at customer plants. Inventory planning and dedicated logistics management supports steady supply even in high-season periods where global demand peaks. Advanced warehouse systems keep stock fresh, and our shipping operations achieve both container-load and incremental delivery schedules.
Direct engagement with technical and procurement teams after purchase builds long-term reliability into each supply relationship. Support covers process integration, analytical troubleshooting, and adaptation to regulatory changes. Staff chemists and engineers collaborate on optimizing use in high-throughput manufacturing, minimizing process waste, managing shelf-life, and resolving any technical questions quickly. Site visits and customer audits are welcomed, as we maintain open lines on technical data and process documentation.
Our vertically integrated capability delivers consistent supply and stable quality profiles, translating into predictable manufacturing costs for downstream users. Customers avoid unexpected process failures or rework due to off-spec material. Strategic, multi-year buyers gain options for order scheduling and supply continuity rare in global chemical markets. With direct shipment from facility to point of use, lead times and sourcing complexity are reduced, and documentation flows directly from production records. Collaboration extends beyond mere supply; it sustains process improvements and total cost control for partners at every stage of the commercial chain.
As the direct manufacturer of Ascorbic Acid, consistent quality draws from strict control at every step of production. Our process begins with pharmaceutical-grade glucose fermentation under sterile conditions, followed by isolation and purification through a carefully monitored processing line. This approach delivers a finished ingredient trusted by food, beverage, and formulation professionals worldwide.
Because product safety and usability matter at every end-use, we maintain a minimum purity of 99.0% for our Ascorbic Acid. We validate this with in-house HPLC and titration methods on each batch before release. Impurities such as related substances rarely cross detection thresholds specified for international compendial grades. Moisture content remains within strict internal controls; we regularly update our testing protocols to align with the most recent pharmacopeial requirements.
The assay for our Ascorbic Acid consistently reaches between 99.0% and 100.5%. Analytical staff perform tests in our in-house laboratory, with calibration routines designed around AOAC, FCC, and EP guidelines. Sampling and assay documentation remain available to qualified partners who request transparency. Routine external audits reinforce our adherence to good manufacturing practice at every facility handling vitamin C synthesis.
Daily experience in manufacturing shows a direct link between raw material purity and process reliability downstream — from blending homogeneity in food plants to solubility in beverages. Any deviation in assay can introduce unpredictable qualities, cause dissolution issues, or skew taste and shelf-life in finished goods. For this reason, we operate precision metering and filtration, minimizing contaminants and guaranteeing a uniform, free-flowing final product with reliable analytic results. The manufacturing floor receives continual feedback from technical support teams who monitor end-user requirements and make sure our QC keeps up.
Years of supplying high-volume, high-regulation markets reveal the critical need for purity confirmation on every shipment. We retain samples from each lot for up to two years, permitting thorough investigation if downstream concerns arise. That commitment reduces the risk of recall or rework and assures our customers—and theirs—of predictable product behavior.
Granularity and physical properties, though not always detailed in public-facing documents, remain tightly specified for blending, mixing, and packaging operations. We support granule size ranges, customize packing weights, and maintain anti-caking practices tailored to frequent requests coming directly from global processors. All modifications pass through our quality department before implementation and are reflected in accompanying certificate of analysis documents on delivery.
Traceability forms a core pillar of our production philosophy, so each drum or carton shipped out carries a unique batch number linked to manufacturing, testing, and release records. This approach supports full backward trace in supply chain audits and rapid corrective action if nonconformance surfaces. Regular training in our QC labs and production units sharpens skills and keeps personnel alert to evolving analytical standards worldwide.
Our Ascorbic Acid production draws on decades of investment in analytical capability and robust manufacturing infrastructure. Clients receive both the documentation and the technical support to meet the most demanding market and regulatory requirements. For those who need full technical dossiers or want to discuss adjustments on particle size or packing, our technical service staff respond quickly and draw on real production data and experience to resolve questions.
Years of operating dedicated ascorbic acid production facilities have given us steady insight into both scale and logistics. The capacity brought by our synthesis lines delivers consistent bulk output for pharmaceutical, food, beverage, and industrial applications. Large-volume customers source directly from us for steady supply assurances, clear documentation, and batch-to-batch consistency.
Our ascorbic acid meets both food and pharmaceutical standards, with clear traceability from raw material intake through every extraction and purification phase. By sticking with rigorous controls, our finished lots exhibit stable color, flow properties, and purity demanded by formulation chemists and process engineers. Downtime from unexpected quality deviations costs everybody in the chain—from blender to packer to distributor. Decades of continuous improvement in our facility workflows means we control risk on every bulk release.
Our plants produce ascorbic acid packaged in industrial drums and composite fiber containers. The minimum order quantity reflects two sides: efficient transit handling and process economics. In our current operation, we set 500 kg as the minimum per order—aligned to one standard drum pallet. This keeps costs competitive and packaging uniform, reduces risk of contamination from unnecessary repacking, and shortens lead times. Our warehousing is built for volume. Smaller runs introduce inefficiencies on both the production line and loading dock, ultimately impacting both margin and reliability across the supply chain.
Bulk orders above our minimum allow us to reserve fresh output within master inventory lots, keep shelf life robust, and simplify regulatory documentation required by our international clients. Food and pharmaceutical partners have the reassurance that each batch gets a unique identifier, complete batch history, and retention samples in line with global best practices.
Manufacturing direct engagement gives us the flexibility to adjust lot sizes and packaging—within industrial norms—when customers run special projects or pilot batches. For clients scaling up from R&D to commercial formulation, our technical support ensures smooth integration. Bulk is more than just raw kilogram numbers. It’s about end-to-end traceability, predictable quality, and zero surprises.
Our bulk contracts prioritize transparency and repeatability. Rather than intermediaries, we open our process lines and documentation to client audits as part of regular partnership reviews. Supply disruptions, price swings, or mysteries about product origin do real harm in competitive markets. Factory-direct relationships limit guesswork and support responsive logistics.
Industry feedback has shaped our packaging, traceability, and process controls. We maintain direct dialogue with procurement teams, formulation specialists, and quality managers who rely on uninterrupted ascorbic acid supplies for their own production planning. Flexibility in documentation, rapid batch certification, and willingness to hold strategic stock on behalf of our major users keep lines moving on both sides of the business relationship.
In our experience as a direct manufacturer, scale and reliability underpin every successful bulk delivery. Access to genuine manufacturer oversight at each production and delivery stage matters most for partners trying to operate with confidence in a competitive global market.
Regulatory compliance in the production of ascorbic acid is not just a checkpoint; it remains a daily operational priority. From raw material sourcing to final packaging, every step falls under our direct oversight, not that of brokers or downstream handlers. Our team oversees the entire process—starting from fermentation and chemical synthesis carried through to post-production refinement—so each batch aligns with current food and pharmaceutical requirements.
Our facilities are periodically audited for compliance with current Good Manufacturing Practice (cGMP) and HACCP guidelines. Only well-maintained, permitted equipment is operated on the main line. Each lot of ascorbic acid produced is routinely sampled and analyzed in our in-house quality lab. All critical specifications—purity, microbiological profile, heavy metals, solvent residues—are confirmed before the product leaves our site. We are prepared to supply actual batch analysis results and retain samples for further verification.
Certification comes standard with every shipment. We deliver a complete Certificate of Analysis (COA) reflecting actual analysis from our own production, not only general specifications. Each COA is traceable back to both the lot and the date of manufacture. Our production and quality assurance records remain available for regulatory review, demonstrating that each batch was monitored at the originating facility.
Material Safety Data Sheets (MSDS), updated and compliant with global hazard communication standards, are always provided. These documents confirm our awareness of both workplace safety and end-product stewardship. All features listed in the MSDS are based on product formulation and hazards as established in our actual plants, not repackaged or rebranded materials.
International shipment now brings higher scrutiny to ingredient origins and compliance documentation. Our export team assumes direct responsibility for preparing every shipment with the proper documentation—country-of-origin certificates, transportation statements, and declaration of conformity—tailored to destination requirements. This is not only a logistics function; it is the manufacturer’s guarantee that what leaves our loading dock is ready for customs and ready for audit. We maintain a history of successful inspections by government agencies, and each shipment carries our name and registration credentials.
Our technical colleagues stand ready to address any regulatory or analytical inquiry directly. If you need a copy of validation methods, residual solvent summaries, non-GMO confirmations, or allergen status, we grant full access to the underlying documentation. If a jurisdiction updates its requirements or a customer standard changes, we adapt our systems and product testing routines. Because we manufacture the material ourselves, we maintain full control over batch testing and can deliver targeted reports on demand.
Direct manufacturers carry the burden and responsibility of compliance through every ton produced. By handling analysis, certification, and export documentation from our own site, we keep the chain of accountability unbroken. Regulatory standards are not barriers; they are baselines for every order that leaves our gates. By delivering documentation and certifications from the source, we help our customers meet their own regulatory challenges and reassure their regulators that every certificate actually matches the origin of the goods. This is the reliability that comes from owning the entire process, batch after batch.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
